The family pharmaceutical business F. Hoffmann-La Roche, leader in its sector, has developed a serological test to detect past infections with COVID-19!

The Swiss family business F. Hoffmann-La Roche, one of the world’s largest pharmaceutical companies, has developed a high-performance serological test, recently approved in the United States by the Food and Drug Administration (FDA). Used to detect antibodies developed following a COVID-19 infection, this test will be used to carry out massive screening of populations. The family business is not at its first scientific innovation. Founded in Switzerland in 1896 by Fritz Hoffmann-La Roche, it is recognized worldwide for the development of innovative medicines and diagnostic tests. With more than 90,000 employees working in more than 100 countries, the family business is, among other things, a leader in the development of treatments for various cancers and a leader in biotechnology. Driven by innovation, the family group invests approximately C $ 12 billion each year in research and development, making it one of the largest R&D investors in the world regardless of the sector.

Read the news: ‘Roche’s COVID-19 antibody test approved by U.S. FDA for emergency use’

Discover the history of F. Hoffman-La Roche…